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Abstract. To determine the role of each intracellular
domain of the fibronectin receptor in receptor distri-
bution, chimeric receptors were constructed containing
the human interleukin-2 receptor (gp55 subunit) as the
extracellular and transmembrane domains, in combina-
tion with either the a5 or ß, intracellular domain of
the fibronectin receptor as the cytoplasmic domain.
These chimeric receptors were transiently expressed in
normal fibroblasts, and their localization on the cell
surface was determined by immunofluorescence using
antibodies to the human interleukin-2 receptor. The a5
chimera was expressed diffusely on the plasma mem-
brane. The 01 chimera, however, colocalized with the
endogenous fibronectin receptor at focal contacts of
cells spread on fibronectin. On cells spread in the
presence of serum, the 01 chimera colocalized both
with the fibronectin receptor at sites of extracellular
fibronectin fibrils and with the vitronectin receptor at
focal contacts. The 01 intracellular domain alone,
therefore, contains sufficient information to target the
chimeric receptor to regions of the cell where ligand-
occupied integrin receptors are concentrated. The find-
T
HE integrins, a family of transmembrane heterodi-
meric receptors consisting of a and ß subunits, play
a central role in cell adhesion and migration. These
processes are important in development, wound healing, me-
tastasis, and other biological events. Integrins function in
both cell-cell and cell-substratum adhesion . Integrin hetero-
dimers can be classifiedinto subfamilies basedon the differ-
ent ß subunits. Different combinations of a and ß subunits
give rise to receptors with different ligand specificities, in-
cluding receptors for fibronectin, vitronectin, collagen, and
laminin. Although some integrins are cell-type specific,
most function in many cell types, and most cell types express
a variety ofintegrin receptors, allowing them to interact with
many extracellular matrix components (recent reviews in-
cludeAkiyama et al., 1990; Albelda and Buck, 1990; Hem-
ler, 1990; Hynes, 1990; Mosher, 1989; Ruoslahti, 1991).
Integrin receptors involved in cell-substratum adhesion
are generally believed to function as transmembrane links
between the extracellular matrix and thecytoskeleton. When
cells form stable adhesions, integrin receptors concentrate
in adhesion sites termed focal contacts. Via their intracellu-
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ing that the 01 chimeric protein behaves like a ligand-
occupied receptor, even though the 01 chimera cannot
itself bind extracellular ligand, suggests an intracellu-
lar difference between occupied and unoccupied recep-
tors, and predicts that the distribution of integrin re-
ceptors can be regulated by ligand occupancy. We tested
this prediction by providing a soluble cell-binding frag-
ment of fibronectin to cells spread on laminin. Under
conditions preventing further ligand adsorption to the
substrate, this treatment nevertheless resulted in the
relocation of diffuse fibronectin receptors to focal con-
tacts. Similarly, a redistribution of diffuse vitronectin
receptors to focal contacts occurred on cells spread on
laminin after the addition of the small soluble peptide
GRGDS. We conclude that the propensity for receptor
redistribution to focal contacts driven by the 01 cyto-
plasmic domain alone is suppressed in heterodimeric
unoccupied fibronectin receptors, and that ligand occu-
pancy can release this constraint . This redistribution
of integrin receptors after the binding of a soluble sub-
strate molecule may provide a direct means of assem-
bling adhesion sites.
lar domains, integrins are thought to interact directly with
some of the cytoskeletal proteins that colocalize with them
at these sites, such as talinand a-actinin (Singer, 1982; Chen
et al., 1985, Damsky et al ., 1985; Horwitz et al., 1986; Bur-
ridge et al., 1988; Tapley et al., 1989 ; Otey et al., 1990).
The integrin 01 intracellular domain is particularly well
conserved in vertebrates from humans to amphibians, sug-
gesting its importance in receptor function (DeSimone and
Hynes, 1988) . This role has been supported by transfection
experiments. By assaying the function ofheterodimers con-
sisting of transfected normal and mutant 01 subunits and
endogenous a subunits, it has been shown that the ß intracel-
lular domain is required for the localization of 01 integrin
receptors in focal contacts (Solowska et al., 1989; Hayashi
et al ., 1990; Marcantonio et al., 1990), as well as its func-
tion in cell adhesion (Hayashi et al., 1990). However, it is
still not known whether the 01 intracellular domain alone is
sufficient for receptor interaction with the cytoskeleton, or
whether in analogy to the requirements for ligand-receptor
interaction, both the a and ß subunits are required for recep-
tor interaction with the cytoskeleton (Buck et al., 1986).
437The distribution of specific integrin receptors at focal con-
tacts is regulated at least in part by the availability of ligand
on the substrate. For example, the fibronectin receptor,
«5ß,, concentrates in focal contacts in cells spread on a
substrate of fibronectin; the vitronectin receptor, aß3, is in
focal contacts in cells spread on vitronectin; and on a colla-
gen substrate, the collagen receptor, a2ß,, is in focal con-
tacts (Singer et al., 1988; Dejana et al ., 1988; Fath et al .,
1989; Carter et al., 1990). However, it is puzzling that the
vitronectin receptor, «vß5, does not localize to focal con-
tacts (Wayner et al., 1991), even though it contains sequence
motifs previously demonstrated to be important in receptor
localization to these adhesion sites (McLean et al., 1990;
Ramaswamy and Hemler, 1990; Marcantonio et al., 1990).
Thus, the molecularmechanismsofthe regulation ofintegrin
receptor distribution and the specific contributions of the
various aspects of receptor function to this process are still
unknown .
To determine the specific roles of each intracellular do-
main of the a5ß1 integrin fibronectin receptor in receptor
distribution, we have constructed chimeric receptors con-
taining the interleukin-2 (IL-2)1 receptor (gp55 subunit) as
theextracellular andtransmembrane domains combined with
either the a5 or ß, intracellular domain of the fibronectin re-
ceptor. These chimeric receptors were transiently expressed
in normal humanand chick embryo fibroblasts, and theirex-
pression was analyzed using antibodies to the IL-2 receptor.
We then analyzed the individual functions of the a5 and ß,
intracellular domains in receptor localization. By using the
IL-2 receptor as a reporter domain, we have been able to dis-
sect the function of each intracellular domain from the func-
tion of ligand binding.
We find that our ßl chimera colocalizes with ligand-
occupied receptors, suggesting that a $1 intracellular do-
main expressed in the absence of a corresponding a5 intra-
cellular domain functions as if it were a ligand-occupied
receptor. Since our 01 chimera cannot itself bind extracel-
lular matrix ligands, and since endogenous unoccupied
receptors are expressed diffusely on the cell surface, our
results suggest that there may be an intracellular difference
between occupied and unoccupied receptors. This notion
predicts that one should be able to change the distribution
ofdiffuse integrin receptors, via an intracellular mechanism,
by the addition ofa soluble ligand. This concept is in contrast
to previous studies of ß, integrins which involved binding
to insoluble, immobile, substrate-attached or fibrillar li-
gands. We tested the ability of soluble ligands and even solu-
ble synthetic peptide ligands, under conditions preventing
their adsorption to substrates, to cause the redistribution of
diffuse integrin receptors to focal contacts. Our results sug-
gest that specific ligand occupancy and the ß, integrin cyto-
plasmic domain play central roles in the regulation of fibro-
nectin receptor distribution.
Materials andMethods
Construction ofChimeric Receptors
Chimeric receptors were constructed using standard molecular biological
techniques (Sambrook et al., 1989) . Each construct was confirmed by
1. Abbreviation used in this paper: IL-2, interleukin 2.
The Journal of Cell Biology, Volume 117, 1992
nucleotide sequence analysis. DNA oligonucleotides were synthesized
using an AppliedBiosystems 380B DNA synthesizer; complementary oligo-
nucleotides were annealed before ligation. The plasmid CMVIL2R (Gior-
danoet al., 1991) was a generous giftofDr. Anthony Giordanoandcontains
the cytomegalovirus LTR directing the transcription of the IL-2 receptor
gp55 subunit (also known as the asubunit) cDNA sequences (Leonard et
al., 1984; Nikaido etal., 1984). To constructthe chimericreceptors, a plas-
mid containing IL-2 receptor cDNA sequences through the membrane do-
main followed by a Lys residue and the stop codon TGA was constructed.
Specifically, theintracellular domainofthe IL-2 receptor was replaced with
a small fragment containing a HindIII site immediately adjacent to the
membrane domain and 3'Xhol site. First, CMVIL2Rs unique HindIII site
was eliminated by digestion with HindIII, extension ofthe resulting 3' ends
with theKlenowfragment ofE. coli DNA polymerase 1, andthe recirculari-
zation ofthe plasmid with T4 DNA ligase. The Nael/Xbal fragment of the
IL-2 receptor cDNA was then replaced with complementary oligonucleo-
tides lA/1B. Oligonucleotides encoding the 01 and a5 intracellular domains
were then inserted between the new HindRI and XhoI sites.
Oligonucleotides IA/1B :
5'-GGCTGTGTTTTCCTGCTGATCAGCGTCCTCCTCCTGAGTGGGCTCACCT
3'-CCGACACAAAAGGACGACTAGTCGCAGGAGGAGGACTCACCCGAGTGGA
GGAAGCTTTAACCCTGCCTCGAGT-3'
CCTTCGAAATTGGGACGGAGCTCAGATC-5'
Oligonucleotides 2A/2B and 3A/3B encode the 01 intracellular domain.
Oligonucleotides 2A/2B:
5'-AGCTTTTAATGATAATTCATGACAGAAGGGAGTTTGCTAAATTTGAAAA
3-AAATTACTATTAAGTACTGTCTTCCCTCAAACGATTTAAACTTTT
GGAGAAAATGAATGCCAAATGGGACACGGGTGAAAATCC-3'
CCTCTTTTACTTACGGTTTACCCTGT-5'
Oligonucleotides 3A/3B:
5-TATTTATAAGAGTGCCGTAACAACTGTGGTCAATCC
3'-GCCCACTTTTAGGATAAATATTCTCACGGCATTGTTGACACCAGTTAGG
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GAAGTATGAGGGAAAATGACC-3'
CTTCATACTCCCTTTTACTGGAGCT-5'
Oligonucleotides 4A/4B and 5A/5B, encoding the a5 intracellular domain
lacking its HindIII site were inserted in plasmid SP72 (Promega, Madi-
son, WI).
Oligonucleotides 4A/4B:
5'-CCTCCTGCTCCTAGGTCTACTCATCTACATCCTCTACAAGCTGGGATTC
GATCCAGATGAGTAGATGTAGGAGATGTTCGACCCTAAG
TTCAAACGCTCCCTCCCATATGGCACCGCCATGGAAAAAGCTCAG
AAGTTTGCGAGGGAGGGTATACCGTGGCGGTACCTTTTTCGAGTC
Oligonucleotides 5A/5B:
5'-CTGAAGCCTCCAGCCACCTCTGATGCCTGACC
3'-GACTTCGGAGGTCGGTGGAGACTACGGACTGGAGCT
The a5 intracellular domain containing a HindIII site at its membrane-
intracellularjunction was amplified from the above plasmid by thepolymer-
ase chain reaction using a PCR kit from Perkin-Elmer Cetus (Norwalk, CT)
using as primers:
Forward primer: 5'-CTCTACAAGCTTGGATTCTTCAACG-3'
Reverse primer: 5-CGTACCTCGAGGTCAGGCATCAGAGG-3:
Cells
Normal human foreskin fibroblasts were a generous gift from Dr. Steve
Alexander (Bethesda Research Laboratories, Gaithersburg, MD) and were
cultured in DME supplementedwith 1 mM glutamine, 50 pg/ml streptomy-
cin, 50 U/ml penicillin, and 10% heat-inactivated FCS. Cell passages 9-18
were used. Chick embryo fibroblasts were prepared as described by Vogt
(1969), and were cultured as above with the additionof 1% heat-inactivated
chicken serum. Cell passages three to five were used.
Purified Proteins, Fragments, andFleptides
Laminin was purchased from BethesdaResearch Laboratories and was also
generously provided by Dr. Hynda Kleinman(National Institutes ofHealth,
Bethesda, MD). The 75-kD cell-binding fragment and the 43-kD collagen-
binding fragment of fibronectin were purified as previously described(Hayashi and Yamada, 1983; Zardi et al., 1985). The synthetic peptides
GRGDS and GRGES were synthesized by Peninsula Laboratories, Inc.
(Belmont, CA) and werepurifiedby molecular sieve chromatography in 1 M
HPLC-grade acetic acid on Bio-Gel P2 columns (Bio-Rad Laboratories,
Richmond, CA). The peptide CAQLKPPATSDA was synthesized with an
Applied Biosystems model 431A peptide synthesizer, purified using a C18
column, and conjugated to keyhole limpet haemocyanin (Pierce Chemical
Co., Rockford, IL) with m-maleimidobenzoic acid-N-hydroxysuccinimide
ester as described by Green et al . (1987).
ImmunologicalReagents
The polyclonal antibody R3134 to the IL-2 receptor (Sharon et al., 1986)
was a generous gift of Dr. Warren Leonard (National Institutes of Health),
and the mouse mAb RPN.512 to the IL-2 receptor's gp55 subunit was pur-
chased from Amersham Chemical Corp. (Arlington Heights, IL). Poly-
clonal antibody 4080 to the 01 intracellular domain has been described
previously (Larjava et al., 1990). Polyclonal antibody 4318 to the as intra-
cellular domain was produced after immunization of rabbits with the pep-
tide CAQLKPPATSDA as described previously for polyclonal antibody
4080 (Larjava et al., 1990). Rat mAb 11 to the as subunit was generated,
characterized, and purified as described for mAb 16 previously (Akiyama
et al., 1989). Because mAb 11 was noninhibitory, its specificity for the as
subunit was further demonstrated by immunostaining mouse 3T3 cells
(ATCC, Rockville, MD) transiently expressing a transfected full-length hu-
man as cDNA (not shown). In addition, after preclearing 35S-labeled cell
lysates withpolyclonalantibody 4318, no additional proteins were immuno-
precipitated with mAb 11, and conversely, after preclearingcell lysates with
mAb 11, no additional proteins were immunoprecipitated with polyclonal
antibody 4318. Polyclonal antibody to the vitronectin receptor, aßß3, was
purchased from Telios (San Diego, CA). mAb 333 has been previously de-
scribed (Akiyama et al., 1985). FITC and rhodamine-labeled second anti-
bodies were purchased from Rockland, Inc. (Gilbertsville, PA).
Immunofluorescence andInterference
Reflection Microscopy
Cells were cultured on glass coverslips as indicated, fixed for 30-60 min
with4% formaldehyde, 5 % sucrose in DulbeccósPBS, then washed several
times inPBS, permeabilized for 5 minin 0.2% Triton X-100 in PBS, washed
several times with PBS, incubated for 30 min in 3% BSA, 0.1% glycine
(pH 7.5) to block nonspecific binding, washed once in PBS, then incubated
for 1 h at ambient temperature with primary antibody in PBS with 1 mg/ml
BSA, then washed for 30 min in PBS with gentle agitation with several
changes of PBS, then incubated with the appropriate FITC- or rhodamine-
conjugated goat antibody and washed as above. The coverglasses were then
mounted on microscope slides with 10% glycerol in PBS containing 1 mg/
ml 1,4-phenylenediamine (Fluka Chemical Corp., Ronkonkoma, NY) to in-
hibit photobleaching (Johnson and Nogueira Araujo, 1981). Adhesions on
theventral cell surface were characterizedby interference reflection micros-
copy (Izzard and Lochner, 1976) by standard methods using an Antiflex
Neofluar 63x/NA 1.25 objectiveon a Zeiss photomicroscope III and photo-
graphed with Kodak technical pan film processed with Diafine developer
(Fuller and d'Albert, Inc., Fairfax, VA).
Transfections
Electroporation of cells was performed as described by Giordano et al.
(1991) at 170 V and 960 uF with a Gene Pulser (Bio-Rad Laboratories).
The expression patterns observed for the as and 01 chimeras were the same
without incubation in sodium butyrate, although the number of transfected
cellsandthe level ofexpressionofthe transfected receptor weresignificantly
lower.
Redistribution ofReceptorsbyLigand Occupancy
Acid-washed glass coverslips were coated with 25 pg/ml laminin overnight
at4°C and thenblocked for 1 h at ambient temperature with 10 mg/ml heat-
denatured BSA (Calbiochem-Behring Corp., San Diego, CA). To prevent
fibronectin synthesis during the course of these experiments, cells were
preincubated for 2 h with 10 mg/ml cycloheximide (Calbiochem-Behring
Corp.), and cycloheximide was then included in all subsequent solutions.
Redistribution studies of the fibronectin receptor were performed by two
protocols.
(Method A) Subconfluent cultures were harvested with trypsin EDTA,
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preincubated at 37°C in suspension in medium prepared with fibronectin-
depleted serum inthe presenceofcycloheximide and 50 Ag/ml antifibronec-
tin mAb 333, and then 1-2 x 105 cells were plated on laminin-coated cov-
erslips in 24-well clusters in serum-free medium + mAb 333 for 90 min.
To reduce the background ofa5ß, fibronecdn receptors in focal contacts in
cells spread for short periods of time on laminin (see also Singer et al.,
1988), we preincubated the cells with mAb 333, which binds near the RGD
site on fibronectin and inhibits the interaction of fibronectin with the fibro-
nectin receptor (data not shown). The cells were then washedseveral times,
fresh serum-free medium containingfragment orpeptide was added as indi-
cated in the figure legends, andthe cells were incubatedat 37°C foran addi-
tional 60 min.
(Method B) Cells were plated on laminin-coated coverslips at 1 x 105
cells per well and allowed to spread overnight in medium prepared with
fibronectin-depleted serum, in the presence of 50 /Ag/ml mAb 333. Cyclo-
heximide was added, andthe cells were then preincubated for 2 h. The cells
werethen washed severaltimes, fresh serum-free medium alone orcontain-
ing 200,ug/ml of the 75-kD fragmentoffibronectin was added, and the cells
were incubated an additional 60 min.
To examine the redistribution ofvitronectin receptors, subconfluent cul-
tures were preincubated for 2 h with cycloheximide. The cells were then
harvested with trypsin-EDTA, washed, and preincubated in suspension for
30 min at 37°C in serum-free medium. Cells were then plated and treated
as described in Method A with mAb 333 omitted.
To determine the number of cells with redistributed fibronectin and
vitronectin receptors, cellswere fixed and stained with either polyclonal an-
tibody 4318 to the as intracellular domain or polyclonal antibody to aß3.
Cells with focalcontacts were located by interferencereflection microscopy,
and the presence of fibronectin or vitronectin receptors was determined by
immunofluorescence. All experiments were analyzed blind, with 100 cells
analyzed for each condition.
Results
Expression oftheChimericReceptors
Chimeric receptors were constructed containing the IL-2
receptor (gp 55 subunit) as the extracellular and transmem-
brane domains, and either the a, or 01 intracellular domain
of the fibronectin receptor as the cytoplasmic domain (Fig.
1) . These chimeric receptors were transiently expressed in
normal human fibroblasts or in chick embryo fibroblasts.
Since fibroblasts do not normally express the IL-2 receptor,
expression and localization ofthe transfected receptors could
be analyzed by immunofluorescence using antibodies to the
IL-2 receptor. Generally 25-50% ofthe transfected cells ex-
pressed the transfected receptor (data not shown; Goldstein
et al., 1989) . Successful cell surface expression of the as
and 01 chimeras was demonstrated by immunofluorescence
staining of non-permeabilized transfected normal human
fibroblasts (Fig. 2, A-D). Although the integrity of these
chimeras was confirmed by nucleotide sequence analysis, we
were also able to demonstrate by immunofluorescence that
Figure 1. The as and 01 chi-
meras. Each chimeracontained
cDNA sequences of the IL-2
receptor gp55 subunitfrom the
NHZ-terminus through Trp
259 at the end of the trans-
membrane domain (Leonard
et al., 1984; Nikaido et al.,
1984), and either the entire
as intracellular domain from Lys 1022 to the translational stop
codon (Argraves et al., 1987) or the entire 0, intracellular domain
from Lys 753 to the translational stop codon (Argraves et al .,
1987).
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440Figure3 . Codistribution of the 01 chimera with the endogenous a5ß1 fibronectin receptor at focal contacts in normal human fibroblasts .
36 h after transfection with either the a5 (A-C) or the 01 (D-F) chimera, cells were pretreated with cycloheximide for 2 h, harvested,
andthen plated for2hon coverslips coated with 10 pg/ml fibronectin . The cells were then double immunostained for the transfected recep-
tor with polyclonal antibodies to the IL-2 receptor at 1:300 dilution (A and D) and for the endogenous fibronectin receptor with mAb
11 at 25 Ag/ml (B andE) with the same regions of the cells shown by interference reflection microscopy (C and F) . Arrows indicate focal
contacts. Bars, 10 am .
Figure2 . Expression of the transfected chimeras . Cell surface expression of the a5 chimera (A and B) or the 01 chimera (C and D) in
normal human fibroblasts . Transfected nonpermeabilized cells stained with mAb RPN.512 to the IL-2 receptor at 7 pg/ml (A and C) are
shownby immunofluorescence or indicated by the arrows in the phase-contrast micrographs (B andD) . Immunostaining ofthe intracellular
domains of the chimeric receptors (E-J) . Chick embryo fibroblasts transfected with either the as chimera, double immunostained with
mAb to the IL-2 receptor (E) and polyclonal antibody 4318 to the a5 intracellular domain at 1:100 dilution (F), or theß1 chimera, double
immunostained with mAb to the IL-2 receptor (H) and polyclonal antibody 4080 to the 01 intracellular domain at 1:100 dilution (I), are
shown by immunofluorescence, or indicated by arrows in phase contrast (G and J) . Bars, 20 um .
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44 1Figure 4. Codistribution of the ß 1 chimera with the endogenous a5ß 1 fibronectin receptor at sites of plasma membrane-fibronectin fibril
association . Normal human fibroblasts transfected with either the a5 (A and B) or the ß1 (C and D) chimera were plated on coverslips
in serum for 36 h and stained for the transfected receptor with polyclonal antibodies to the IL-2 receptor (A and C) and for the endogenous
fibronectin receptor with mAb 11 (B and D) . Arrowheads indicate regions where the 01 chimera colocalizes with the endogenous fibro-
nectin receptor at sites where extracellular fibronectin fibrils are associated with the plasma membrane, whereas arrows indicate the lack
of colocalization of the as chimera with the endogenous fibronectin receptor at these sites . Bar, 10 jm .
the a s and 01 intracellular domains were correctly trans-
lated . Polyclonal antibodies 4080 and 4318 recognize the hu-
man 01 and as intracellular domains respectively. The poly-
clonal antibody to thehumanas intracellular domain showed
only weak staining of endogenous avian receptors (untrans-
fected cells in Fig. 2F and our unpublished observations) .
The human as chimera transiently expressed in chick em-
bryo fibroblasts could be detected with either themAb to the
IL-2 receptor (Fig. 2E) or the polyclonal antibody tohuman
ci5 intracellular domain (Fig . 2 F) . Although the human
and avian 01 intracellular domains are identical, cells tran-
siently expressing the 01 chimera at high levels could be de-
tected with either the mAb to the IL-2 receptor (Fig. 2 H)
or the polyclonal antibody to the 0 1 intracellular domain
(Fig . 2 I), whereas the nontransfected cells could not (Fig .
2 J and our unpublished observations) . These results estab-
lished that the intracellular domains were correctly expressed
at the protein level as well .
Localization ofthe Chimeric Receptors
When fibroblasts spread on a fibronectin substrate, their
a5ß 1 fibronectin receptors concentrate in focal contacts
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(Singer et al ., 1988). To establish whether either the a2 or
01 intracellular domain alone can determine where the chi-
meric receptors localize, normal human fibroblasts tran-
siently expressing these chimeras were plated for 2 h on
fibronectin-coated coverslips, and the expression of the
transfected and endogenous receptors in focal contacts was
analyzed by inununofluorescence and interference reflection
microscopy. The as chimera was expressed diffusely on the
plasma membrane even in cells that had their endogenous
fibronectin receptors concentrated in focal contacts (Fig . 3,
A-C) . The 01 chimera, however, localized to focal contacts
in patterns similar to those of endogenous receptors (Fig . 3,
D-F), indicating that the 0 1 intracellular domain itself is
sufficient to target the chimeric receptor to focal contacts .
When fibroblasts are plated in serum for 24 h ormore on
uncoated coverslips, their a5ß, fibronectin receptors be-
come concentrated at sites where extracellular fibronectin
fibrils are associated with the plasma membrane, and their
vitronectin receptors become concentrated at focal contacts
(Singer et al ., 1988) . To determine whether either the a5 or
0 1 intracellular domain alone was sufficient to target the
chimeric receptors to sites of cell contact with fibronectin
442Figure S . Codistribution of the 01 chimera with the vitronectin receptor at focal contacts in normal human fibroblasts spread in serum .
Cells transfected with either the as (A-C) or the 01 (D-F) chimera were plated in serum for 36 h and then double immunostained with
mAb to the IL-2 receptor (A and D) and polyclonal antibodies to the vitronectin receptor at 1:50 dilution (B and E), with the same regions
of the cell shown by interference reflection microscopy (C and F) . Focal contacts are indicated by arrows . Bar, 10 Am .
fibrils, human fibroblasts transiently transfected with the
chimeric receptors were plated on coverslips in serum-
containing medium for 36 h . The 0 1 chimera was found to
be colocalized with the fibronectin receptor at sites ofplasma
membrane-fibronectin fibril association (Fig. 4, C and D) .
Therefore, the ß, intracellular domain was also sufficient to
target receptors to other regions of the cell where ligand-
occupied receptors were concentrated . However, its most
striking localization was still at focal contacts, where
vitronectin receptors also localized (Fig . 5, D-F) .
The as chimera was again found to be expressed dif-
fusely in the plasma membrane even in cells where endog-
enous fibronectin receptor was concentrated at sites of fibro-
nectin fibril formation (Fig. 4, A and B), and in contrast to
the 01 chimera, it did not colocalize with the vitronectin re-
ceptor at focal contacts (Fig. 5, A-C) . This diffuse expres-
sion pattern of the a s chimera suggested that it was either
insufficient for receptor localization or that it encoded a
dominant negative element for receptor localization . To dis-
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tinguish between these two possibilities, we examined the ex-
pression of a transfected IL-2 receptor lacking an intracellu-
lar domain (see Materials and Methods) . We found that like
the as chimera, it also showed diffuse membrane staining,
indicating that the as chimera lacked sufficient information
for receptor localization (not shown) . However, the as in-
tracellular domain may act as a negative element in the het-
erodimeric unoccupied receptor suppressing the propensity
for receptor redistribution to focal contacts driven by 01 in-
tracellular domain . Ligand occupancy may release this con-
straint .
Redistribution of the a5Nt Fibronectin Receptor by
Ligand Occupancy
Since our ßl chimera does not contain an extracellular do-
main that can bind extracellular matrix ligands, its distribu-
tion at focal contacts is most likely determined by its interac-
tion with the cytoskeleton . The 01 intracellular domain
expressed in the absence of an a5 intracellular domainmay
443The Journal of Cell Biology, Volume 117, 1992
30 -
20
t
3
y 10-
Z
0
o -4 G) c> w 41
￿
C) li
ó m v D u
￿
ó
Figure 6. Redistribution of the asg, fibronectin receptor by ligand
occupancy. (A) Normal human fibroblasts pretreated as described
in Materials and Methods were incubated on laminin-coated cover-
slips for 90min. Thecellswere incubated an additional 60minwith
fresh medium alone or with either 100 jig/ml of the 75-kD cell-
binding fragment of fibronectin, or BSA, or the 43-kD collagen-
binding fragment of fibronectin, or either 500 jug/ml GRGES or
GRGDS. The percent cells with a501 in focal contacts was deter-
minedas described in Materials and Methods. (B) Cells pretreated
as described in Materials and Methods were incubated on laminin-
coated coverslips for 15 h and were then incubated for an additional
60 min after the addition of freshmedium alone or containing 200
,ug/ml of the 75-kD cell-binding fragment of fibronectin.
interact with the cytoskeleton in a manner similar to an oc-
cupied receptor, suggesting that occupied receptors may
concentrate at focal contacts not only because they bind
ligand absorbed to the substrate, but also because they have
an enhanced ability to interact with cytoskeletal proteins at
these sites. If receptor distribution is regulated by the recep-
tor's ability to interact with the cytoskeleton rather than by
the availability of substrate-bound ligand, then one would
predict that receptor distribution should change by the addi-
tion of even a soluble ligand. This prediction was tested by
allowing cells to spread on laminin in serum-free medium
for 90 min, after which most fibronectin receptors were
found diffusely distributed in the plasma membrane. The
75-kD cell-binding fragment of fibronectin was then added
and the cells were incubated for an additional 1 h. Redistri-
bution of diffuse fibronectin receptors to focal contacts was
evaluated by immunofluorescence and interference reflection
microscopy. As shown in Fig. 6A, occupancy with the 75-kD
fragment resulted in a redistribution of diffuse asß, fibro-
nectin receptors to focal contacts. Incubation with the small
peptide GRGDS containing the fibronectin RGD adhesion
sequence (Ruoslahti and Pierschbacher, 1987; Yamada, 1991)
also resulted in the redistribution ofdiffuse fibronectin recep-
tors to focal contacts, whereas the control peptide GRGES,
BSA, and the 43-kD collagen-binding fragment of fibronec-
tin did not.
To determine whether the redistribution of asßl occurs in
cells plated for longer periods of time with more mature fo-
cal contacts, we plated cells on laminin substrates for 15 h
in fibronectin-depleted medium in the presence of sufficient
amounts of mAb 333 to blockthe interaction of endogenous
fibronectin with the fibronectin receptor. This pretreatment
resulted in a diffuse distribution of the fibronectin receptor
in the cell membrane. Treatment with the 75-kD fragment
under these conditions resulted in a similar redistribution of
diffuse fibronectin receptors to focal contacts. This redistri-
bution of the fibronectin receptor is shown quantitatively in
Fig. 6 B and by immunofluorescence in Fig. 7.
Redistributión ofOtherIntegrinsbyLigand Occupancy
The relocation of receptors by ligand binding may be a
general characteristic of integrin receptors. The vitronectin
receptor (4, binds readily to the small peptide GRGDS
(Pytela et al., 1985). When this small soluble peptide was
added to cells spread on a laminin substrate, redistribution
ofvitronectin receptors to focalcontacts was observed, simi-
lar to what was seen for fibronectin receptors (Fig. 8). The
redistribution of the vitronectin receptor did not occur with
the addition of the control peptide GRGES, BSA, or the
43-kD collagen binding fragment of fibronectin.
Discussion
Understanding the biology of the fibronectin receptor and
other integrin receptors requires the identification of the
functional domains ofthese receptors. To determine whether
the as and 01 intracellular domains of the fibronectin recep-
tor can function as separate domains, we constructed chi-
meric receptors containing either the as or the 01 intracel-
lular domain with the IL-2 receptor gp55 subunit as the
common extracellular and transmembrane domains. The de-
termination of protein domain function by deletion analysis
is always difficult because ofthe possibility that a particular
deletion or mutation may affect the conformation ofthe pro-
tein. Therefore, we have used the alternative approach of
testing for gain-of-function by the addition of a specific do-
main. Using the IL-2 receptor portion as a reporter domain,
we were able to characterize the function of each intracellu-
lar domain individually and independently of the receptor's
ability to bind to ligand. We were able to (a) define function
for the 01 intracellular domain, and (b) analyze the role of
ligand occupancy in the regulation ofintegrin receptordistri-
bution.
We found that the 01 intracellular domain alone was
sufficient to target the reporter domain to regions of the cell
where ligand-occupied receptors were concentrated, such as
focal contacts and sites of association between the cell and
extracellular fibronectin fibrils. Our results confirm a central
role for the ß, intracellular domain in receptor localization,
but they also establish that the 01 intracellular domain is not
only required, but is in fact sufficientby itselfto target recep-
tor localization to focal contacts. In addition, since the as
chimera was expressed relatively diffusely on the cell sur-
face, we can further conclude that the as intracellular do-
main is not sufficient to determine receptor localization.
However, we cannot rule out the possibility that the as in-
tracellular domain plays a supportive or regulatory role in
receptor distribution and function, or that it plays a more ac-
tive role in receptor localization in other cell types. Interest-
ingly, the al,b intracellular domain of the platelet receptor,
«11nß3, functions in the regulation of ligand binding affinity,
and the as intracellular domain cannot substitute for the «116
intracellular domain in this regulation (O'Toole et al., 1991).
The localization of the 01 chimera to focal contacts on
cells plated on a fibronectin substrate suggests that it binds
444Figure 7 . Redistribution of a5ß, by ligand occupancy as shown by immunofluorescence . Normal human fibroblasts were incubated for
15 h on laminin-coated coverslips, and then incubated an additional 1 h with fresh medium alone (A and C) or with 200 Ag/ml 75-kD
cell binding fragment (B and D) . Cells stained with polyclonal antibody 4318 to the a5 intracellular domain at 1:100 dilution are shown
by immunofluorescence (A and B) or by interference reflection microscopy (C and D) . Bar, 10 Am .
the same cytoskeletal proteins that bind the endogenous
fibronectin receptors concentrated at these sites . The ß,
chimera also localized to focal contacts in cells plated in se-
rum, suggesting that it also binds to proteins in focal contacts
formed by vitronectin receptors . The 03 and ß, intracellular
domainsmay bind to the same cytoskeletal protein, since the
N3 and ß, intracellular domains have considerable homol-
ogy (Argraves et al ., 1987 ; Fitzgerald et al ., 1987) and
colocalize with the same cytoskeletal proteins at adhesion
sites (Fath et al ., 1989) . Interestingly, the 03 intracellular
domain can substitute for the ß, intracellular domain in het-
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tronectin receptors by ligand
occupancy. Normal human
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scribed in MaterialsandMeth-
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erodimeric fibronectin receptor localization and function
(Solowska et al., 1991) .
The major cytoplasmic difference between the ß, chi-
mera and the endogenous fibronectin receptor is the absence
of the as intracellular domain in the ß, chimera . This fact
taken together with colocalization of the ß, chimera with
endogenous ligand-occupied receptors, suggests that the a5
intracellular domain may inhibit the ability of the Q, intra-
cellular domain of unoccupied endogenous receptors to in-
teract with cytoskeletal proteins, and further suggests that a
change in the endogenous receptor occurs upon ligand bind-
ing that results in an unmasking of the ß, intracellular do-
main or regions ofthe intracellular domain that interact with
specific cytoskeletal proteins. The idea thatthe context ofthe
ß, intracellular domain may affect its affinity for specific
cytoskeletal proteins is supported by in vitro binding studies
in which the ß, intracellular domain expressed as a peptide
had a higher affinity for a-actinin than the purified intact het-
erodimeric receptor (Otey et al ., 1990) . On the other hand,
receptor interaction with talin requires an intact, heterodi-
meric receptor for binding (Buck et al ., 1986) . These results
support the notion that the availability ofbinding sites on the
ß, intracellular domainmay be affected by the co intracellu-
lar domain . However, an alternative possibility is that ligand
binding, instead of unmasking the ß intracellular domain,
changes the conformation of the ß intracellular domain into
a higher affinity or "active" conformation capable ofinteract-
ing with the cytoskeleton, and that our ß, chimera has an
intracellular domain in this `active" conformation .
445The hypothesis that occupied receptors have an enhanced
ability to interact with the cytoskeleton suggests a mecha-
nism by which ligand could determine the localization of
receptors, not only by the availability of substrate-bound
ligand, but in addition by the receptor's ability to interact
with specific cytoskeletal proteins. We tested this possibility
by the addition of soluble ligands for either the a5ß,
fibronectin receptor or the vitronectin receptor to cells
spread on laminin and found that ligand occupancy targeted
diffuse receptors to heterologous focal contacts. This redis-
tribution of receptors occurred even with small peptide
ligands, ensuring that the striking redistribution observed
was not due to receptors binding to ligands absorbing to the
substrate, since the use of GRGDS as a substrate requires
covalent linkage to a carrier protein (Singer et al ., 1987) .
Furthermore, redistribution of receptors occurred both in
cellsspread for 90 min with newly formed focal contacts and
in cells spread for 15 h with more stable and mature focal
contacts. Additionally, when the experiment was performed
with cells spread on vitronectin instead of laminin, both the
vitronectin and fibronectin receptors were in the same focal
contacts (data not shown) . In some cell types, both cell-bind-
ing and heparin-binding domains of fibronectin are required
for focal contact formation (Izzard et al., 1986; Woods et al.,
1986). In the redistribution experiments with normal human
fibroblasts, the cell-binding domain was sufficientfor the re-
distribution of the fibronectin receptor to focal contacts.
Generally, integrin receptors do not concentrate at focal
contacts unless their ligand is absorbed to the substrate
(Singer et al., 1988; Dejana et al ., 1988; Fath et al., 1989;
Carter et al ., 1990) . Similarly the distribution of the
fibronectin receptor with plasma membrane-associated
fibronectin fibrils requires the interaction of the fibronectin
receptor with extracellular fibrils (Chen et al., 1986; Gian-
cottiet al., 1986; Akiyama et al., 1989; Roman et al., 1989).
These previous experiments demonstrated that the regula-
tion of integrin receptor distribution requires the interaction
of the receptor with its ligand and that the distribution of
ligand determines the distribution of its receptor. However,
these experiments implied that the regulation of integrin dis-
tribution by ligand occupancy is largely extracellular. The
results of our chimeric receptor experiments taken together
with our receptor redistribution experiments suggest a major
internal control of receptor distribution regulated by ligand
occupancy. Our results support the hypothesis that a confor-
mational change occurs in some integrin receptors that en-
hance their ability to interact with particular cytoskeletal
proteins and that this enhanced ability to interact with the
cytoskeleton can determine receptor distribution. This intra-
cellular control of receptor distribution provides a simple
mechanism for recruitment of integrin receptors with their
bound ligand to adhesion sitesand sitesofextracellular fibril
formation.
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